Topamax Recall 2011
On April 14th, 2011 Ortho-McNeil-Janssen announced a Topamax recall covering two lots of 100 mg tablets due to consumer reports of an unusual odor. Recently the Food and Drug Administration also announced a warning for women who are pregnant or might become pregnant regarding using Topamax during the first trimester of pregnancy. The FDA warning stated that there was new data showing evidence of an increased risk for the development of cleft lip and cleft palate (oral clefts) in infants born to women who used Topamax (Topiramate) during pregnancy.
|Package Description||NDC Code||Lot Number||Expiry|
|TOPAMAX® (topiramate) TABLETS 100mg Bottles of 60 Tablets||50458-641-65||0KG110||06-2012|
TOPAMAX® 100mg Tablets are yellow with “OMN” on one side and “100” on the other. The manufacturer is not recommending any consumer actions, however patients taking TOPAMAX® 100mg Tablets who experience an uncharacteristic odor associated with their medication should return the tablets to their pharmacist, and contact their doctor or medical provider if they have questions regarding lots of the medication subject to the Topamax recall.
Topamax Recall News
If your child has suffered from Topamax cleft palate birth defects please contact us for a free no-obligation consultation. We are currently investigating cases for families involving Topamax side effects that occurred after using this drug during pregnancy. For the latest news and updates and information on filing a Topamax lawsuit 2011 claim please call or e-mail us today.